| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8284619 | Maturitas | 2011 | 6 Pages |
Abstract
In both groups of women with and without VMS, HT use does not seem to be associated with the risk of CHD. Hence, our findings do not support the view that HT use increases the CHD risk among women with an indication, i.e. VMS, but this needs to be confirmed in specifically designed studies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Gerrie-Cor M. Gast, Victor J.M. Pop, Göran N. Samsioe, Diederick E. Grobbee, Peter M. Nilsson, Jules J. Keyzer, Colette J.M. Wijnands-van Gent, Yvonne T. van der Schouw,